Cargando…

Construction of a clinical survival prognostic model for middle-aged and elderly patients with stage III rectal adenocarcinoma

BACKGROUND: Nomograms for prognosis prediction in colorectal cancer patients are few, and prognostic indicators differ with age. AIM: To construct a new nomogram survival prediction tool for middle-aged and elderly patients with stage III rectal adenocarcinoma. METHODS: A total of 2773 eligible pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hao, Li, Yu, Qu, Yi-Dan, Zhao, Jun-Jiang, Zheng, Zi-Wen, Jiao, Xue-Long, Zhang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942048/ https://www.ncbi.nlm.nih.gov/pubmed/33728300 http://dx.doi.org/10.12998/wjcc.v9.i7.1563

Ejemplares similares

Pre-treatment platelet counts as a prognostic and predictive factor in stage II and III rectal adenocarcinoma
por: Steele, Morgan, et al.
Publicado: (2017)

Contemporary, national patterns of surgery after preoperative therapy for stage II/III rectal adenocarcinoma
por: Soriano, Celine, et al.
Publicado: (2022)

Prognostic value of vascular endothelial growth factor receptor 1 and class III β-tubulin in survival for non-metastatic rectal cancer
por: Kong, Xiang-Quan, et al.
Publicado: (2018)

Tumor-stroma ratio as prognostic factor for survival in rectal adenocarcinoma: A retrospective cohort study
por: Scheer, René, et al.
Publicado: (2017)

Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery?
por: Reggiani Bonetti, Luca, et al.
Publicado: (2017)

Survival benefits and disparities in radiation therapy for elderly patients with pancreatic ductal adenocarcinoma
por: Cao, Bi-Yang, et al.
Publicado: (2023)

Prognostic significance of primary tumor localization in stage II and III colon cancer
por: Sakin, Abdullah, et al.
Publicado: (2018)

Predictive value of a serum tumor biomarkers scoring system for clinical stage II/III rectal cancer with neoadjuvant chemoradiotherapy
por: Zhao, Jie-Yi, et al.
Publicado: (2022)

Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer
por: Suenaga, Yasuhito, et al.
Publicado: (2019)

No long-term survival benefit with sustained-release 5-fluorouracil implants in patients with stages II and III gastric cancer
por: Wu, Yun-Zi, et al.
Publicado: (2022)

Modified Gant procedure for treatment of internal rectal prolapse in elderly women
por: Xu, Peng-Peng, et al.
Publicado: (2021)

Prognostic factors for disease-free survival in postoperative patients with hepatocellular carcinoma and construction of a nomogram model
por: Luo, Pan-Quan, et al.
Publicado: (2022)

Trends with neoadjuvant radiotherapy and clinical staging for those with rectal malignancies
por: Reddy, Sanjay S, et al.
Publicado: (2017)

Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer
por: Kim, Jae Hyun, et al.
Publicado: (2017)

Radiomics of rectal cancer for predicting distant metastasis and overall survival
por: Li, Mou, et al.
Publicado: (2020)

Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer
por: Cho, Jang Ho, et al.
Publicado: (2017)

Assessment of T and N staging with MRI(3)T in lower and middle rectal cancer and impact on clinical strategy
por: Xu, Liping, et al.
Publicado: (2020)

PIK3CA and TP53 mutations predict overall survival of stage II/III colorectal cancer patients
por: Li, A-Jian, et al.
Publicado: (2018)

Model established based on blood markers predicts overall survival in patients after radical resection of types II and III adenocarcinoma of the esophagogastric junction
por: Wei, Zhi-Jian, et al.
Publicado: (2022)

Blood parameters score predicts long-term outcomes in stage II-III gastric cancer patients
por: Lin, Jian-Xian, et al.
Publicado: (2019)

Optimal postoperative surveillance strategies for stage III colorectal cancer
por: Park, Min Young, et al.
Publicado: (2021)

Postoperative survival analysis and prognostic nomogram model for patients with portal hypertension
por: Zhang, Ya-Fei, et al.
Publicado: (2018)

Impact of resection margins on long-term survival after pancreaticoduodenectomy for pancreatic head carcinoma
por: Li, Cheng-Gang, et al.
Publicado: (2019)

Stage III should be subclassified into Stage IIIA and IIIB in the American Joint Committee on Cancer (8(th) Edition) staging system for pancreatic cancer
por: Yu, Hai-Feng, et al.
Publicado: (2018)

Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer
por: Cheong, Chinock, et al.
Publicado: (2020)

Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer
por: Cai, Du, et al.
Publicado: (2019)

Prognostic effect of excessive chemotherapy cycles for stage II and III gastric cancer patients after D2 + gastrectomy
por: Li, Yi-Fan, et al.
Publicado: (2023)

Prediction of different stages of rectal cancer: Texture analysis based on diffusion-weighted images and apparent diffusion coefficient maps
por: Yin, Jian-Dong, et al.
Publicado: (2020)

Prognostic Significance of Lymph Node Ratio in Stage III Rectal Cancer
por: Shin, Jin Yong, et al.
Publicado: (2011)

Dissimilar survival and clinicopathological characteristics of mucinous adenocarcinoma located in pancreatic head and body/tail
por: Li, Zheng, et al.
Publicado: (2023)

Outcomes and prognostic factors of patients with stage IB and IIA pancreatic cancer according to the 8(th) edition American Joint Committee on Cancer criteria
por: Li, Yang, et al.
Publicado: (2017)

Prediction of cancer-specific survival and overall survival in middle-aged and older patients with rectal adenocarcinoma using a nomogram model
por: Liu, Hao, et al.
Publicado: (2020)

Improving the accuracy and consistency of clinical target volume delineation for rectal cancer by an education program
por: Zhang, Yang-Zi, et al.
Publicado: (2022)

Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma
por: Geng, Zhi-Min, et al.
Publicado: (2019)

Utility of Restaging MRI Following Neoadjuvant Chemoradiotherapy for Stage II-III Rectal Adenocarcinoma
por: Aryan, Mahmoud, et al.
Publicado: (2021)

Pathological response to neoadjuvant therapy with chemotherapy vs chemoradiotherapy in stage III NSCLC-contribution of IASLC recommendations
por: Muñoz-Guglielmetti, Diego, et al.
Publicado: (2021)

Albumin-to-alkaline phosphatase ratio: A novel prognostic index of overall survival in cholangiocarcinoma patients after surgery
por: Xiong, Jian-Ping, et al.
Publicado: (2019)

Prognostic value of lymph nodes count on survival of patients with distal cholangiocarcinomas
por: Lin, Hua-Peng, et al.
Publicado: (2018)

Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy
por: Wei, Fang-Ze, et al.
Publicado: (2020)

Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours
por: Thomaschewski, Michael, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0c67p289f57a4hqk40kd7nffh4